Sign In
Buy CBAY
$32.48
+0 (+0%)
At Close: Apr 11, 2024
Here's Why CymaBay Therapeutics Rose 109% in May
09:53pm, Tuesday, 09'th Jun 2020
The development-stage company might be able to resume the development of its lead drug candidate, which was halted in late 2019.
Notice of Change of Location of Annual Meeting of Stockholders to be Held on June 23, 2020
09:00pm, Friday, 05'th Jun 2020
CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that, due to
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics
02:22pm, Tuesday, 02'nd Jun 2020
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics
5 Top Stocks Up 100%+ in May With More Room to Run
12:34pm, Monday, 01'st Jun 2020
Reopening of the economy, vaccine hopes and stimulus measures helped Wall Street climb north in May and squash the old adage "sell in May and go away."
Is CymaBay’s Seladelpar Back in the Saddle? 5-Star Analyst Weighs In
10:12pm, Tuesday, 26'th May 2020
In the world of biotechs, all it takes is a single piece of good news to change the narrative. This has been exemplified by none other than CymaBay Therapeutics (CBAY), which is focused on developing
HC Wainwright & Co. Upgrades CymaBay Therapeutics to Buy, Announces $9 Price Target
11:29am, Tuesday, 26'th May 2020Will Good News Boost This Small-Cap Drug Company's Stock Even Higher?
11:21am, Thursday, 21'st May 2020
Shares of CymaBay Therapeutics (NASDAQ: CBAY) have climbed nearly 143% since last week after it got great news about its orphan drug, seladelpar. A phase 2B trial for the drug to see how it did agai
Engine Capital Management, LLC Buys Super Micro Computer Inc, CIM Commercial Trust Corp, KBR ...
12:00am, Monday, 18'th May 2020Is CymaBay Therapeutics (CBAY) Stock a Solid Choice Right Now?
12:29pm, Friday, 15'th May 2020
CymaBay Therapeutics (CBAY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Do Options Traders Know Something About CymaBay Therapeutics (CBAY) Stock We Don't?
01:37pm, Wednesday, 13'th May 2020
Investors need to pay close attention to CymaBay Therapeutics (CBAY) stock based on the movements in the options market lately.
CymaBay (CBAY) Stock Is up 127% in a Day. How Much Higher Can It Go?
12:18pm, Wednesday, 13'th May 2020
Six months ago, disturbing liver biopsies suggesting some patients in an FDA Phase 2b study of CymaBay Therapeutics (CBAY) suffered inflamed and destroyed liver cells forced the company to suspend non
